Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In the SUSTAIN trial, 52% of patients receiving semaglutide experienc ed gastrointestinal side effects, compared with 35% in the placebo group
doi:10.1016/j.drugalcdep.2020.107890 Hayes BT, Li Y, Crystal S, et al
Share and Cite Harvard Style Roy, S
Launch dates for the new system are shown below for the Highmark segments where we serve as a General Agency Distribution Channel: Pennsylvania (all regions) Launch on Monday, April 28 th , 2025 West Virginia Launch on Monday, April 14 th , 2025 If you are an NFP BNGA Producer Partner that relies on the support of our NFP BNGA team for renewal actions and New Business Quotes/Implementation through the system: This change will not impact you directly our team will continue to transact in the system on your behalf
Monitor Dosage: Avoid exceeding recommended amounts to prevent unintended side effects
A total of 1961 obese or overweight patients with comorbidities were enrolled
